Innovation, Experience, and Quality

Article

The One Use-Plus SBK, the new generation of LASIK microkeratomes, achieves accuracy and visual results equivalent to femtolasers at a fraction of the cost.

For nearly two centuries, Moria has developed, manufactured, and distributed sophisticated, high quality, innovative ophthalmic surgical instrumentation and equipment that contribute to improved surgical outcomes.

The One Use-Plus SBK, the new generation of LASIK microkeratomes, achieves accuracy and visual results equivalent to femtolasers… at a fraction of the cost. The One Use-Plus SBK produces predictable, thin flaps with planar profiles, resulting in outstanding visual outcomes that are equivalent or better than those attained with a femtolaser. This excellent performance is achieved with less discomfort to the patient, none of the complications associated with the laser, and at a significantly lower cost to the refractive practice.

Working closely with leading corneal surgeons, Moria has been at the forefront of the DSAEK revolution and helped make it the surgical procedure of choice for posterior corneal pathologies. Today Moria, more than ever, is keeping ahead with a promising new technique, Ultra-Thin DSAEK.

The One® range of single-use, high precision, hand-held surgical instruments provide increased safety, convenience, and efficiency in cataract surgery. It’s the guarantee of 100% cleanliness and sterility for each patient and the guarantee of new, precise, undamaged instruments for each procedure.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.